A systematic review of predictive models for recurrence and mortality in patients with tongue cancer.
Por:
Palazón-Bru A, Mares-García E, López-Bru D, Mares-Arambul E, Gil-Guillén VF and Carbonell-Torregrosa MÁ
Publicada:
1 nov 2019
Ahead of Print:
23 ago 2019
Resumen:
INTRODUCTION: Predictive models must meet clinical/methodological standards to be used in clinical practice. However, no critique of those models relating to mortality/recurrence in tongue cancer has been done bearing in mind the accepted standards. METHODS: We conducted a systematic review evaluating the methodology and clinical applicability of predictive models for mortality/recurrence in tongue cancer published in MEDLINE and Scopus. For each model, we analysed (domains of CHARMS, Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies) the following: source of data, participants, outcome to be predicted, candidate predictors, sample size, missing data, model development, model performance, model evaluation, results and interpretation and discussion. RESULTS: We found two papers that included eight prediction models, neither of which adhered to the CHARMS recommendations. CONCLUSION: Given the quality of tongue cancer models, new studies following current consensus are needed to develop predictive tools applicable in clinical practice.
Filiaciones:
:
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain
Mares-García E:
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain
López-Bru D:
Department of Otolaryngology, General University Hospital of Elche, Elche, Spain
Mares-Arambul E:
Department of Otolaryngology, General University Hospital of Elda, Elda, Spain
:
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain
Carbonell-Torregrosa MÁ:
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain
Emergency Service, General University Hospital of Elda, Elda, Spain
|